Nicotine

Qnovia, Inc. Announces the Appointment of Four New Members to its Scientific Advisory Board

Retrieved on: 
Tuesday, April 9, 2024
Science, Biotechnology, Research, Pharmaceutical, Health, Tobacco, Clinical Trials, Retail, Disease, Cardiovascular Research, Society, IND, Psychology, Therapy, Senior counsel, Population health, School, Dean (education), Partnership, Nicotine, Policy, Smoker, Behavior, NIH, Brown University, Trial of the century, University, SAB, Pharmacology, Homelessness, San Francisco General Hospital, UCSF, Public, Cancer, MD, Publication, Heated tobacco product, Hospital, Juul, FDA, Alpert Medical School, Pregnancy, Chair, Public health, University of Kansas, Cardiology, CTA, Mortality, Louisiana State University, Doctor of Philosophy, MHRA, Smoking, Toxicology, Division, Brown, Social science, Pharmaceutical industry

“We believe our proprietary drug-device combination platform has the potential to be a first-in-class and best-in-class treatment for smoking cessation.

Key Points: 
  • “We believe our proprietary drug-device combination platform has the potential to be a first-in-class and best-in-class treatment for smoking cessation.
  • Last fall, QN-01 demonstrated a superior pharmacokinetic profile compared to existing nicotine replacement therapies in our first-in-human Phase 1 clinical trial.
  • We plan to submit our IND and CTA to the regulatory bodies and look forward to commencing our Phase 1/2 clinical study this year.
  • He also served a three-year term on the Board of the Society for Research on Nicotine and Tobacco.

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

Retrieved on: 
Wednesday, March 20, 2024
Research, Harvard Medical School, Massachusetts General Hospital, Nicotine, Smoker, NIH, Society, Smoking, Safety, Bangladesh Technical Education Board, Annual general meeting, Tobacco

March 21, 2024, 11:30 AM GMT: Achieve’s Director of Clinical Operations, Roxann Becco, will present patient-reported outcomes from the Phase 3 ORCA-2 and ORCA-3 clinical trials.

Key Points: 
  • March 21, 2024, 11:30 AM GMT: Achieve’s Director of Clinical Operations, Roxann Becco, will present patient-reported outcomes from the Phase 3 ORCA-2 and ORCA-3 clinical trials.
  • Data collected include trial participants’ experiences, such as cravings and withdrawal symptoms, personal impact on overall health, and opinions on future use.
  • ORCA-V1 evaluated the effectiveness and safety of cytisinicline in users of nicotine e-cigarettes who wanted to quit vaping.
  • The content is the sole responsibility of the authors and does not necessarily represent the official views of the NIH.

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

Retrieved on: 
Thursday, March 14, 2024
Webcast, International, Smoking, Nicotine

SEATTLE and VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its fourth quarter and year-end 2023 financial results and provide an update on the cytisinicline development program on Thursday, March 28, 2024, at 4:30 PM EST.

Key Points: 
  • SEATTLE and VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its fourth quarter and year-end 2023 financial results and provide an update on the cytisinicline development program on Thursday, March 28, 2024, at 4:30 PM EST.
  • To access the webcast, please use the following link 4Q23 Webcast .
  • Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. & Canada) or 201-689-7817 (International) and referencing conference ID 13744140.
  • A webcast replay will be available approximately three hours after the call and will be archived on the website for 90 days.

HUNY Enters Nationwide Recreational Substance Industry With First-of-its-Kind Arecoline Honey Mint

Retrieved on: 
Wednesday, March 13, 2024
Areca, THC, Nicotine, Honey, Caffeine, Video game

DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- HUNY (“the Company”), creators of the world’s first and only arecoline honey consumable, is shaking up the recreational substance market with a nationwide release of HUNY.

Key Points: 
  • DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- HUNY (“the Company”), creators of the world’s first and only arecoline honey consumable, is shaking up the recreational substance market with a nationwide release of HUNY.
  • HUNY is made from honey that naturally contains arecoline, the active ingredient in areca or betel nuts.
  • Arecoline is the fourth most commonly used recreational substance in the world and is incredibly popular throughout Asia.
  • For more information about HUNY, arecoline honey, and where to find this exciting new product, you can connect with HUNY on their website .

Worldwide Anti-Smoking Policies Charted in Comprehensive Index

Retrieved on: 
Wednesday, April 3, 2024
Other Policy Issues, Women, Men, Other Retail, General Health, Tobacco, Public Safety, Public Policy, Government, Other Health, Consumer, Advocacy Group Opinion, Retail, Oncology, Other Communications, Communications, Convenience Store, Philanthropy, Health, White House, Federal Government, Foundation, Herbal cigarette, Innovation, Global health, History, Smoking, European, THP, Nicotine, Multimedia

We Are Innovation, a leading global innovation network, released the 2024 Effective Anti-Smoking Policies Global Index ( https://antismoking.global/ ).

Key Points: 
  • We Are Innovation, a leading global innovation network, released the 2024 Effective Anti-Smoking Policies Global Index ( https://antismoking.global/ ).
  • The Index delves into the intricacies of alternative nicotine products, scrutinizing aspects such as regulatory frameworks, prohibitions, taxation, and governmental measures for switching from smoking.
  • View the full release here: https://www.businesswire.com/news/home/20240402477735/en/
    The top 20 countries in the global anti-smoking index, led by the United Kingdom, Sweden, and Slovakia in the podium positions, collectively impact almost 1 billion people worldwide.
  • The index emphasizes the urgent need for global advancements in anti-smoking policies.

3X Upgrade! Meet with VOOPOO's New Super Pods ARGUS P2&G2

Retrieved on: 
Friday, March 22, 2024
Tobacco, Retail, Longevity, Taste, MTL, Heat, RDL, ARGUS, Nicotine, P1, Multimedia, Video game

The two new super pods come with a 3X upgrade, fully upgrading the user's vaping experience.

Key Points: 
  • The two new super pods come with a 3X upgrade, fully upgrading the user's vaping experience.
  • View the full release here: https://www.businesswire.com/news/home/20240321764139/en/
    Recommended Retail Price: ARGUS P2:$34.99 ARGUS G2:$35.99 (Photo: Business Wire)
    ARGUS P2 and ARGUS G2 are the second generation of VOOPOO's flagship pods, ARGUS P1 and ARGUS G. Compared with the predecessors, the new two products feature higher power and larger screens.
  • The “3X upgrade” means that the new ARGUS top fill cartridge achieves comprehensive upgrades in three aspects: leakage, longevity and flavor.
  • Meet VOOPOO's new super pods ARGUS P2 & G2 with 3X upgrade.

Philip Morris International Launches New IQOS ILUMA i in Japan to Accelerate the Achievement of a Smoke-Free Future

Retrieved on: 
Wednesday, March 13, 2024
Technology, Tobacco, Retail, Consumer Electronics, Smoke, Philip Morris International, Taste, Olczak, Science, Risk, PMI, Research, Smoker, Sale, Life, ZYN, System, Nicotine, IQOS, Toxicology, Q3, Aluminium, Government, Food

1 tobacco heating system.1 The launch also marks the 10-Year anniversary of IQOS, originally launching in Nagoya, Japan in 2014.

Key Points: 
  • 1 tobacco heating system.1 The launch also marks the 10-Year anniversary of IQOS, originally launching in Nagoya, Japan in 2014.
  • Within 10 years, IQOS net revenues have surpassed those for Marlboro, making it the number one international nicotine brand and accelerated the decline of cigarettes in many countries.
  • In Japan, for example, nearly one-third of adult smokers are using IQOS2 and cigarette sales have declined much more rapidly since heated tobacco was launched.
  • It is important that others—like government authorities and regulators—embrace the opportunity offered by innovation and science to benefit the world.”
    The IQOS ILUMA i series offers three devices in Japan: IQOS ILUMA i PRIME, IQOS ILUMA i and IQOS ILUMA i ONE.

ICCPP ODM+ Presents OPOD: A Recap of the Sensational Presence at Vapexpo2024 in France

Retrieved on: 
Thursday, March 28, 2024
Temperature, Attention, Herbal cigarette, Risk, Eye, Exhibition, Nicotine, Mesh, Safety, Tobacco

PARIS, March 28, 2024 /PRNewswire/ -- ICCPP ODM+ stole the show at Vapexpo 2024 in Paris with their groundbreaking product, OPOD.

Key Points: 
  • PARIS, March 28, 2024 /PRNewswire/ -- ICCPP ODM+ stole the show at Vapexpo 2024 in Paris with their groundbreaking product, OPOD.
  • This exceptional sustainable pod system e-cigarette solution garnered immense attention and left a lasting impression on the vaping industry.
  • Let's take a moment to highlight the key moments and achievements of ICCPP ODM+ at this prestigious event.
  • In addition, ICCPP ODM+ presented their state-of-the-art ultra-thin pod system solution, BLADE X, at Vapexpo2024, featuring the powder-free GENE TREE ceramic coil technology.

Opod Open, Slay Your Fortune! ICCPP ODM+'s Compliant and Sustainable Pod System Vape Solution to Surprise Debut at VAPEXPO24!

Retrieved on: 
Monday, March 25, 2024
Freedom, Taste, Environment, Recycling, ODM, System, Nicotine, Marketing, AirPods, Tobacco

ICCPP ODM+, the innovative ODM business of VOOPOO's parent company, will be looking forward to your visit at Booth A12 with the "OPOD" unprecedented sustainable pod system solution and numerous TPD-compliant products!

Key Points: 
  • ICCPP ODM+, the innovative ODM business of VOOPOO's parent company, will be looking forward to your visit at Booth A12 with the "OPOD" unprecedented sustainable pod system solution and numerous TPD-compliant products!
  • With the slogan of "Opod Open, Slay Your Fortune", OPOD is a creative sustainable pod system vape solution that perfectly combines modern innovation with aesthetic art.
  • It is no exaggeration to say that at the first sight of OPOD, you can perceive the minimalist beauty of the design.
  • In addition, OPOD is equipped with a powerful 500mAh battery, which can fully meet the needs of 2ml pod for one-time vaping.

E-Cigarette Market Data - Interactive Dashboards with Data on Flavours and Nicotine Strengths by Leading Brands and Top Websites in 7 Major Markets - US, UK, Russia, Germany, France, Italy and Canada

Retrieved on: 
Monday, March 25, 2024
Nicotine, Database, Data collection, Benchmarking, Prevalence, Tobacco, NIC

Analysts have compiled these interactive dashboards to enable convenient navigation of market data about the flavours and nicotine strengths offered by leading brands and top websites in seven major e-cigarette markets: the US, UK, Russia, Germany, France, Italy, and Canada.

Key Points: 
  • Analysts have compiled these interactive dashboards to enable convenient navigation of market data about the flavours and nicotine strengths offered by leading brands and top websites in seven major e-cigarette markets: the US, UK, Russia, Germany, France, Italy, and Canada.
  • The data can be filtered according to category - such as product, nicotine, flavour or component type - and see which ones are increasing or decreasing their market share.
  • What you can find in the flavour tracker:
    Flavour profiles per brand, flavour components and the evolution of the most popular flavours since 2017.
  • What you can find in the nicotine strength tracker:
    Nicotine concentration analysis of new products added by websites compared to the previous quarter.